Aethlon Medical (AEMD)
Aethlon Medical on one page: short interest, daily short volume, fails to deliver, large holders, 13F holders, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as surgical & medical instruments & apparatus.
33K
Short interest
settlement 2026-10-15
1.0
Days to cover
unchanged vs prior
35.2%
Short share of volume
2026-11-02
7,239
Fails to deliver
settlement 2026-10-14
Wed 11 Nov
Next earnings
estimated date
$0
Insider flow, 90 days
0 buys, 0 sells
As of 2026-11-02.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 15 October 2026, short interest in AEMD is 32,925 shares, down 41,921 shares over the last month. Over the last 48 readings it ranged from 12,511 shares (15 December 2025) to 1,737,538 shares (15 January 2025). The latest reading sits at the bottom of that range. At the reported average volume of 57K shares a day that is 1.0 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/aemd" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-10-15 | 32,925 | -56.4% | 57,317 | 1.00 |
| 2026-09-30 | 75,446 | +0.8% | 8,417,425 | 1.00 |
| 2026-09-15 | 74,846 | -83.8% | 184,597 | 1.00 |
| 2026-08-31 | 461,661 | +609.4% | 5,622,745 | 1.00 |
| 2026-08-14 | 65,075 | -71.9% | 65,331 | 1.00 |
| 2026-07-31 | 231,654 | +1.4% | 165,334 | 1.40 |
| 2026-07-15 | 228,466 | +4.6% | 167,061 | 1.37 |
| 2026-06-30 | 218,384 | +16.6% | 258,775 | 1.00 |
| 2026-06-15 | 187,291 | -43.3% | 370,446 | 1.00 |
| 2026-05-29 | 330,345 | +1045.3% | 3,203,228 | 1.00 |
| 2026-05-15 | 28,844 | +105.3% | 59,037 | 1.00 |
| 2026-04-30 | 14,050 | -60.0% | 12,279 | 1.14 |
| 2026-04-15 | 35,087 | +149.7% | 12,286 | 2.86 |
| 2026-03-31 | 14,053 | -80.2% | 33,376 | 1.00 |
| 2026-03-13 | 70,872 | -18.1% | 121,713 | 1.00 |
| 2026-02-27 | 86,540 | +21.8% | 23,841 | 3.63 |
| 2026-02-13 | 71,042 | +41.1% | 37,153 | 1.91 |
| 2026-01-30 | 50,339 | +86.6% | 80,151 | 1.00 |
| 2026-01-15 | 26,978 | +30.7% | 63,869 | 1.00 |
| 2025-12-31 | 20,645 | +65.0% | 33,320 | 1.00 |
| 2025-12-15 | 12,511 | -41.9% | 456,161 | 1.00 |
| 2025-11-28 | 21,517 | -48.8% | 29,309 | 1.00 |
| 2025-11-14 | 42,005 | +13.5% | 40,188 | 1.05 |
| 2025-10-31 | 36,998 | -72.2% | 69,118 | 1.00 |
| 2025-10-15 | 133,219 | +41.4% | 595,038 | 1.00 |
| 2025-09-30 | 94,200 | +76.1% | 293,276 | 1.00 |
| 2025-09-15 | 53,484 | -93.2% | 1,705,472 | 1.00 |
| 2025-08-29 | 780,598 | +544.5% | 16,150,163 | 1.00 |
| 2025-08-15 | 121,116 | +41.9% | 168,750 | 1.00 |
| 2025-07-31 | 85,343 | -62.8% | 99,018 | 1.00 |
| 2025-07-15 | 229,563 | +47.8% | 812,562 | 1.00 |
| 2025-06-30 | 155,344 | +448.3% | 477,461 | 1.00 |
| 2025-06-13 | 28,330 | -70.1% | 76,696 | 1.00 |
| 2025-05-30 | 94,651 | +9.6% | 115,334 | 1.00 |
| 2025-05-15 | 86,349 | -15.4% | 200,867 | 1.00 |
| 2025-04-30 | 102,085 | +81.9% | 94,112 | 1.08 |
| 2025-04-15 | 56,128 | -60.4% | 102,982 | 1.00 |
| 2025-03-31 | 141,641 | -44.5% | 126,156 | 1.12 |
| 2025-03-14 | 255,384 | -46.7% | 207,198 | 1.23 |
| 2025-02-28 | 479,417 | -52.0% | 267,310 | 1.79 |
| 2025-02-14 | 998,088 | -27.4% | 570,821 | 1.75 |
| 2025-01-31 | 1,374,561 | -20.9% | 1,026,870 | 1.34 |
| 2025-01-15 | 1,737,538 | +46.6% | 1,948,058 | 1.00 |
| 2024-12-31 | 1,185,424 | +200.3% | 14,817,752 | 1.00 |
| 2024-12-13 | 394,720 | +94.1% | 319,584 | 1.24 |
| 2024-11-29 | 203,400 | -42.1% | 196,817 | 1.03 |
| 2024-11-15 | 351,097 | +22.7% | 530,781 | 1.00 |
| 2024-10-31 | 286,148 | -4.4% | 242,566 | 1.18 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 2 November 2026, the short share of AEMD volume is 35.2%, up 14.9 points over the last five sessions. Over the last 30 readings it ranged from 16.4% (27 October 2026) to 71.0% (19 October 2026). The latest reading is 8.6 points below the 30-session average of 43.8%, on 37K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-11-02 | 13K | 37K | 35.2% | 0 |
| 2026-10-30 | 9K | 14K | 64.8% | 0 |
| 2026-10-29 | 2K | 3K | 54.3% | 0 |
| 2026-10-28 | 9K | 33K | 27.2% | 7 |
| 2026-10-27 | 3K | 19K | 16.4% | 0 |
| 2026-10-26 | 591 | 3K | 20.3% | 1 |
| 2026-10-23 | 2K | 6K | 28.9% | 0 |
| 2026-10-22 | 34K | 52K | 65.1% | 0 |
| 2026-10-21 | 2K | 5K | 30.3% | 0 |
| 2026-10-20 | 4K | 9K | 46.8% | 0 |
| 2026-10-19 | 20K | 28K | 71.0% | 0 |
| 2026-10-16 | 8K | 14K | 59.6% | 0 |
| 2026-10-15 | 16K | 34K | 47.9% | 5,824 |
| 2026-10-14 | 13K | 41K | 31.6% | 0 |
| 2026-10-13 | 4K | 12K | 32.7% | 0 |
| 2026-10-12 | 3K | 11K | 27.9% | 0 |
| 2026-10-09 | 3K | 6K | 43.1% | 0 |
| 2026-10-08 | 3K | 12K | 27.8% | 0 |
| 2026-10-07 | 4K | 11K | 33.1% | 300 |
| 2026-10-06 | 17K | 28K | 60.0% | 0 |
| 2026-10-05 | 17K | 60K | 28.5% | 0 |
| 2026-10-02 | 10K | 24K | 41.4% | 0 |
| 2026-10-01 | 11K | 23K | 46.4% | 0 |
| 2026-09-30 | 25K | 45K | 56.7% | 0 |
| 2026-09-29 | 13K | 25K | 52.4% | 1,454 |
| 2026-09-28 | 31K | 61K | 51.6% | 0 |
| 2026-09-25 | 34K | 56K | 61.3% | 73 |
| 2026-09-24 | 25K | 58K | 44.1% | 0 |
| 2026-09-23 | 78K | 149K | 52.2% | 7,440 |
| 2026-09-22 | 160K | 294K | 54.5% | 1,018 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 14 October 2026, the fails-to-deliver balance in AEMD is 7,239 shares, up 4,358 shares over the last settlement date. Over the last 30 readings it ranged from 1 share (12 August 2026) to 246,697 shares (18 September 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-10-14 | 7,239 | $5.58 | $40K |
| 2026-10-13 | 2,881 | $5.86 | $17K |
| 2026-10-08 | 6,836 | $6.07 | $41K |
| 2026-10-07 | 6,113 | $6.09 | $37K |
| 2026-10-06 | 4,603 | $6.53 | $30K |
| 2026-10-02 | 2,196 | $6.63 | $15K |
| 2026-10-01 | 463 | $6.52 | $3K |
| 2026-09-30 | 2,156 | $6.38 | $14K |
| 2026-09-29 | 1,807 | $6.38 | $12K |
| 2026-09-25 | 7,512 | $6.77 | $51K |
| 2026-09-24 | 4,146 | $6.81 | $28K |
| 2026-09-23 | 8,013 | $6.57 | $53K |
| 2026-09-22 | 8,043 | $6.32 | $51K |
| 2026-09-21 | 30,097 | $6.31 | $190K |
| 2026-09-18 | 246,697 | $6.78 | $1.7M |
| 2026-09-17 | 2,359 | $1.43 | $3K |
| 2026-09-16 | 2,505 | $1.47 | $4K |
| 2026-09-14 | 887 | $1.53 | $1K |
| 2026-09-04 | 17,193 | $1.93 | $33K |
| 2026-09-03 | 4,802 | $1.82 | $9K |
| 2026-09-01 | 4,653 | $2.06 | $10K |
| 2026-08-31 | 8,551 | $2.49 | $21K |
| 2026-08-28 | 206,434 | $2.17 | $448K |
| 2026-08-25 | 3,058 | $2.64 | $8K |
| 2026-08-19 | 4,831 | $2.89 | $14K |
| 2026-08-12 | 1 | $3.18 | $3 |
| 2026-08-10 | 156 | $3.15 | $491 |
| 2026-08-07 | 18 | $3.02 | $54 |
| 2026-08-06 | 3,288 | $3.25 | $11K |
| 2026-08-05 | 13,507 | $3.52 | $48K |
Insider trades
SEC Form 4, newest first. JSONNo open-market insider trades were reported for AEMD in the last 90 days. The most recent filings are listed below. Latest filing: LAROSA STEVEN P (Chief Medical Officer) on 2026-10-08.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-10-08 | LAROSA STEVEN P | Chief Medical Officer | Grant | 42K | $0.00 | $0 | 42K |
| 2026-10-08 | FRAKES JAMES B | CFO/CEO | Grant | 42K | $0.00 | $0 | 42K |
| 2026-09-30 | BROENNIMAN EDWARD G | Director | Tax withholding | 218 | $6.52 | $1K | 4K |
| 2026-09-30 | Gikakis Nicolas | Director | Tax withholding | 436 | $6.52 | $3K | 4K |
| 2026-09-30 | Shah Chetan | Director | Tax withholding | 436 | $6.52 | $3K | 4K |
| 2026-06-30 | Shah Chetan | Director | Tax withholding | 2K | $0.82 | $2K | 21K |
| 2026-06-30 | Gikakis Nicolas | Director | Tax withholding | 2K | $0.82 | $2K | 21K |
| 2026-06-30 | BROENNIMAN EDWARD G | Director | Tax withholding | 1K | $0.82 | $895 | 22K |
| 2026-04-17 | Rossetti Angela | Director | Grant | 22K | $2.29 | $50K | 26K |
| 2026-04-17 | Shah Chetan | Director | Grant | 22K | $2.29 | $50K | 23K |
| 2026-04-17 | Gikakis Nicolas | Director | Grant | 22K | $2.29 | $50K | 23K |
| 2026-04-17 | BROENNIMAN EDWARD G | Director | Grant | 22K | $2.29 | $50K | 23K |
| 2026-03-31 | Shah Chetan | Director | Tax withholding | 178 | $2.19 | $390 | 1K |
| 2026-03-31 | Gikakis Nicolas | Director | Tax withholding | 178 | $2.19 | $390 | 1K |
| 2026-03-31 | BROENNIMAN EDWARD G | Director | Tax withholding | 89 | $2.19 | $195 | 2K |
| 2025-12-31 | Shah Chetan | Director | Tax withholding | 179 | $2.77 | $496 | 2K |
| 2025-12-31 | Gikakis Nicolas | Director | Tax withholding | 179 | $2.77 | $496 | 2K |
| 2025-12-31 | BROENNIMAN EDWARD G | Director | Tax withholding | 89 | $2.77 | $247 | 3K |
| 2025-09-30 | Shah Chetan | Director | Tax withholding | 2K | $0.75 | $1K | 23K |
| 2025-09-30 | BROENNIMAN EDWARD G | Director | Tax withholding | 893 | $0.75 | $669 | 25K |
| 2025-09-30 | Gikakis Nicolas | Director | Tax withholding | 2K | $0.75 | $1K | 23K |
| 2025-06-30 | BROENNIMAN EDWARD G | Director | Tax withholding | 893 | $1.20 | $1K | 22K |
| 2025-06-30 | Gikakis Nicolas | Director | Tax withholding | 2K | $1.20 | $2K | 20K |
| 2025-06-30 | Shah Chetan | Director | Tax withholding | 2K | $1.20 | $2K | 20K |
| 2025-04-23 | Shah Chetan | Director | Grant | 143K | $0.36 | $51K | 174K |
| 2025-04-23 | BROENNIMAN EDWARD G | Director | Grant | 143K | $0.35 | $50K | 182K |
| 2025-04-23 | Rossetti Angela | Director | Grant | 143K | $0.35 | $50K | 343K |
| 2025-04-23 | Gikakis Nicolas | Director | Grant | 143K | $0.35 | $50K | 174K |
| 2025-03-31 | Gikakis Nicolas | Director | Tax withholding | 3K | $0.36 | $1K | 31K |
| 2025-03-31 | Shah Chetan | Director | Tax withholding | 3K | $0.36 | $1K | 31K |
| 2025-03-31 | BROENNIMAN EDWARD G | Director | Tax withholding | 2K | $0.36 | $592 | 39K |
| 2024-12-31 | Gikakis Nicolas | Director | Tax withholding | 3K | $0.86 | $3K | 35K |
| 2024-12-31 | Shah Chetan | Director | Tax withholding | 3K | $0.86 | $3K | 35K |
| 2024-12-31 | BROENNIMAN EDWARD G | Director | Tax withholding | 2K | $0.86 | $1K | 41K |
| 2024-09-30 | Shah Chetan | Director | Tax withholding | 3K | $0.47 | $2K | 38K |
| 2024-09-30 | BROENNIMAN EDWARD G | Director | Tax withholding | 2K | $0.47 | $773 | 42K |
| 2024-09-30 | Gikakis Nicolas | Director | Tax withholding | 3K | $0.47 | $2K | 38K |
| 2024-06-28 | BROENNIMAN EDWARD G | Director | Tax withholding | 2K | $0.50 | $823 | 44K |
| 2024-06-28 | Gikakis Nicolas | Director | Tax withholding | 5K | $0.50 | $3K | 41K |
| 2024-06-28 | Shah Chetan | Director | Tax withholding | 3K | $0.50 | $2K | 41K |
| 2024-04-16 | Gikakis Nicolas | Director | Grant | 33K | $1.52 | $50K | 47K |
| 2024-04-16 | Shah Chetan | Director | Grant | 33K | $1.52 | $50K | 45K |
| 2024-04-16 | Rossetti Angela | Director | Grant | 33K | $1.52 | $50K | 201K |
| 2024-04-16 | BROENNIMAN EDWARD G | Director | Grant | 33K | $1.52 | $50K | 45K |
| 2024-03-29 | Shah Chetan | Director | Tax withholding | 1K | $1.68 | $2K | 12K |
| 2024-03-29 | BROENNIMAN EDWARD G | Director | Tax withholding | 1K | $1.68 | $2K | 13K |
| 2024-03-29 | Gikakis Nicolas | Director | Tax withholding | 2K | $1.68 | $3K | 14K |
| 2023-12-29 | Shah Chetan | Director | Tax withholding | 1K | $2.19 | $3K | 13K |
| 2023-12-29 | BROENNIMAN EDWARD G | Director | Tax withholding | 1K | $2.19 | $3K | 14K |
| 2023-12-29 | Gikakis Nicolas | Director | Tax withholding | 2K | $2.19 | $4K | 16K |
| 2023-09-29 | Gikakis Nicolas | Director | Tax withholding | 20K | $0.23 | $4K | 176K |
| 2023-09-29 | BROENNIMAN EDWARD G | Director | Tax withholding | 12K | $0.23 | $3K | 149K |
| 2023-09-29 | Shah Chetan | Director | Tax withholding | 12K | $0.23 | $3K | 140K |
| 2023-07-03 | Gikakis Nicolas | Director | Grant | 195K | $0.00 | $0 | 195K |
| 2023-06-30 | BROENNIMAN EDWARD G | Director | Tax withholding | 12K | $0.36 | $4K | 161K |
| 2023-06-30 | Shah Chetan | Director | Tax withholding | 12K | $0.36 | $4K | 151K |
| 2023-04-28 | Shah Chetan | Director | Grant | 116K | $0.00 | $0 | 163K |
| 2023-04-28 | Rossetti Angela | Director | Grant | 116K | $0.00 | $0 | 168K |
| 2023-04-28 | BROENNIMAN EDWARD G | Director | Grant | 116K | $0.00 | $0 | 172K |
| 2023-03-31 | BROENNIMAN EDWARD G | Director | Tax withholding | 3K | $0.39 | $1K | 56K |
| 2023-03-31 | Shah Chetan | Director | Tax withholding | 3K | $0.39 | $1K | 47K |
| 2022-12-30 | BROENNIMAN EDWARD G | Director | Tax withholding | 3K | $0.28 | $959 | 59K |
| 2022-12-30 | Shah Chetan | Director | Tax withholding | 3K | $0.28 | $959 | 50K |
| 2022-09-30 | Shah Chetan | Director | Tax withholding | 7K | $0.58 | $4K | 53K |
| 2022-09-30 | BROENNIMAN EDWARD G | Director | Tax withholding | 7K | $0.58 | $4K | 63K |
| 2022-09-15 | Shah Chetan | Director | Grant | 34K | $0.00 | $0 | 60K |
| 2022-09-15 | BROENNIMAN EDWARD G | Director | Grant | 34K | $0.00 | $0 | 70K |
| 2022-09-15 | Rossetti Angela | Director | Grant | 51K | $0.00 | $0 | 51K |
| 2022-03-31 | Shah Chetan | Director | Tax withholding | 2K | $1.46 | $4K | 26K |
| 2022-03-31 | BROENNIMAN EDWARD G | Director | Tax withholding | 2K | $1.46 | $4K | 35K |
| 2022-03-31 | JOHNSON SABRINA MARTUCCI | Director | Tax withholding | 2K | $1.46 | $4K | 34K |
| 2021-12-31 | JOHNSON SABRINA MARTUCCI | Director | Tax withholding | 2K | $1.86 | $5K | 36K |
| 2021-12-31 | Shah Chetan | Director | Tax withholding | 2K | $1.86 | $5K | 28K |
| 2021-12-31 | BROENNIMAN EDWARD G | Director | Tax withholding | 2K | $1.86 | $5K | 38K |
| 2021-09-30 | Shah Chetan | Director | Tax withholding | 2K | $3.86 | $9K | 31K |
| 2021-09-30 | JOHNSON SABRINA MARTUCCI | Director | Tax withholding | 2K | $3.86 | $9K | 39K |
| 2021-09-30 | BROENNIMAN EDWARD G | Director | Tax withholding | 2K | $3.86 | $9K | 40K |
| 2021-06-30 | BROENNIMAN EDWARD G | Director | Tax withholding | 2K | $4.91 | $12K | 43K |
| 2021-06-30 | Shah Chetan | Director | Tax withholding | 2K | $4.91 | $12K | 33K |
| 2021-06-30 | JOHNSON SABRINA MARTUCCI | Director | Tax withholding | 2K | $4.91 | $12K | 41K |
| 2021-04-01 | JOHNSON SABRINA MARTUCCI | Director | Grant | 24K | $2.06 | $50K | 43K |
| 2021-04-01 | BROENNIMAN EDWARD G | Director | Grant | 24K | $2.06 | $50K | 45K |
| 2021-04-01 | Shah Chetan | Director | Grant | 24K | $2.06 | $50K | 36K |
| 2021-03-31 | JOHNSON SABRINA MARTUCCI | Director | Tax withholding | 3K | $2.03 | $5K | 19K |
| 2021-03-31 | BROENNIMAN EDWARD G | Director | Tax withholding | 3K | $2.03 | $5K | 21K |
| 2021-03-31 | Shah Chetan | Director | Tax withholding | 3K | $2.03 | $5K | 11K |
| 2021-03-31 | FISHER CHARLES J JR | Chief Executive Officer | Tax withholding | 3K | $2.03 | $5K | 20K |
| 2021-03-31 | Cipriani Guy F. | Sr. V.P., Chief Bus. Officer | Tax withholding | 3K | $2.03 | $5K | 18K |
| 2020-12-31 | Shah Chetan | Director | Tax withholding | 3K | $2.47 | $6K | 14K |
| 2020-12-31 | JOHNSON SABRINA MARTUCCI | Director | Tax withholding | 3K | $2.47 | $6K | 22K |
| 2020-12-31 | BROENNIMAN EDWARD G | Director | Tax withholding | 3K | $2.47 | $6K | 23K |
| 2020-12-31 | Cipriani Guy F. | Director | Tax withholding | 3K | $2.47 | $6K | 20K |
| 2020-12-31 | FISHER CHARLES J JR | Chief Executive Officer | Tax withholding | 3K | $2.47 | $6K | 22K |
| 2020-12-17 | Shah Chetan | Director | Sell | 334 | $2.09 | $698 | 17K |
| 2020-12-17 | Shah Chetan | Director | Sell | 5K | $2.10 | $11K | 17K |
| 2020-12-17 | Shah Chetan | Director | Sell | 21K | $2.11 | $45K | 22K |
| 2020-09-30 | Cipriani Guy F. | Director | Tax withholding | 2K | $1.35 | $3K | 23K |
| 2020-09-30 | BROENNIMAN EDWARD G | Director | Tax withholding | 2K | $1.35 | $3K | 26K |
| 2020-09-30 | Shah Chetan | Director | Tax withholding | 2K | $1.35 | $3K | 43K |
| 2020-09-30 | FISHER CHARLES J JR | Director | Tax withholding | 2K | $1.35 | $3K | 25K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON1 holder reports 5% or more of AEMD in its latest filing, on Schedule 13G (passive). The holder is JANE STREET GROUP, LLC at 5.0% of the class (35,819 shares), filed 2026-10-13 for an event on 2026-10-06.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-10-13 | 13G | JANE STREET GROUP, LLCparent holding company | 36K | 5.0% | 2026-10-06 |
| 2026-10-13 | 13G | Jane Street Global Trading, LLCother entity | 29K | 4.1% | 2026-10-06 |
| 2026-10-13 | 13G | Jane Street Capital, LLCbroker-dealer | 7K | 1.0% | 2026-10-06 |
| 2026-08-13 | 13G/Ano. 2 | Intracoastal Capital LLCother entity | 56K | 2.3% | 2026-06-30 |
| 2026-08-13 | 13G/Ano. 2 | Mitchell P. Kopinparent holding company, individual | 56K | 2.3% | 2026-06-30 |
| 2026-08-13 | 13G/Ano. 2 | Daniel B. Asherparent holding company, individual | 56K | 2.3% | 2026-06-30 |
| 2026-05-15 | 13G/Ano. 1 | Armistice Capital, LLCinvestment adviser, other entity | 82K | 5.0% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 1 | Steven Boydparent holding company, individual | 82K | 5.0% | 2026-03-31 |
| 2026-02-17 | 13G/Ano. 1 | Alumni Capital LPpartnership | 56K | 4.0% | 2025-10-31 |
| 2026-02-17 | 13G/Ano. 1 | Alumni Capital GP LLCother entity | 56K | 4.0% | 2025-10-31 |
| 2026-02-17 | 13G/Ano. 1 | Ashkan Maparindividual | 56K | 4.0% | 2025-10-31 |
| 2025-11-14 | 13G/Ano. 1 | Ikarian Capital, LLCinvestment adviser | 15K | 2.0% | 2025-09-30 |
| 2025-11-14 | 13G/Ano. 1 | Neil Shahrestaniindividual, parent holding company | 15K | 2.0% | 2025-09-30 |
13F holders
Tracked managers holding AEMD at their latest 13F. JSON1 of the 30 tracked managers held AEMD at their latest 13F, $35K in total at quarter-end prices. Citadel Advisors is the largest at $35K (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 1 added shares and 0 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Citadel Advisors | 2026-06-30 | 43K | $35K | 0.00% | new |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
What this page is
Aethlon Medical in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows Aethlon Medical (AEMD), SEC CIK 882291, listed on Nasdaq, classified by the SEC as surgical & medical instruments & apparatus. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-11-02.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-10-14.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-10-13.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-13.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-10-08.JSON and CSV
- Company record
- EDGAR filing index for CIK 882291Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as surgical & medical instruments & apparatus
Other company pages
Datasets
Frequently Asked Questions
How much of AEMD is sold short?
32,925 shares were held short at the 2026-10-15 settlement, 1.0 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is AEMD's daily short volume?
On 2026-11-02, 12,905 of the 36,668 AEMD shares reported to FINRA were sold short, 35.2% of the day's reported volume. Short volume is a flow for one day, not a position.
Does AEMD have fails to deliver?
The SEC's latest file shows 7,239 AEMD shares failed to deliver at settlement 2026-10-14. Fails are reported per settlement date and published twice a month with a lag.
Are AEMD insiders buying or selling?
No open-market insider trades were reported for AEMD in the last 90 days. The most recent filings are listed below. Latest filing: LAROSA STEVEN P (Chief Medical Officer) on 2026-10-08.
Who owns 5% or more of AEMD?
1 holder reports 5% or more of AEMD in its latest filing, on Schedule 13G (passive). The holder is JANE STREET GROUP, LLC at 5.0% of the class (35,819 shares), filed 2026-10-13 for an event on 2026-10-06.
Which tracked 13F managers own AEMD?
1 of the 30 tracked 13F managers held AEMD shares at their latest filing, $35K in all. The largest: Ken Griffin's Citadel Advisors (43K shares, $35K).
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.